JAFL
Jay A. Fishman Ltd Portfolio holdings
AUM
$1.04B
This Quarter Return
+7.38%
1 Year Return
+20.25%
3 Year Return
+102.32%
5 Year Return
+197.1%
10 Year Return
+481.9%
AUM
$949M
AUM Growth
+$949M
(+4.8%)
Cap. Flow
+$13.5M
Cap. Flow
% of AUM
1.42%
Top 10 Holdings %
Top 10 Hldgs %
72.53%
Holding
93
New
3
Increased
26
Reduced
33
Closed
7
Top Buys
| 1 |
Meta Platforms (Facebook)
META
|
$4.39M |
| 2 |
NVIDIA
NVDA
|
$4.2M |
| 3 |
American Express
AXP
|
$2.39M |
| 4 |
Merck
MRK
|
$1.31M |
| 5 |
Zoetis
ZTS
|
$1.26M |
Top Sells
| 1 |
Apple
AAPL
|
$2.99M |
| 2 |
Johnson & Johnson
JNJ
|
$2.49M |
| 3 |
GXO Logistics
GXO
|
$1.97M |
| 4 |
Diageo
DEO
|
$1.49M |
| 5 |
PNC Financial Services
PNC
|
$1.39M |
Sector Composition
| 1 | Technology | 34.39% |
| 2 | Financials | 15.98% |
| 3 | Communication Services | 14.02% |
| 4 | Consumer Discretionary | 12.69% |
| 5 | Healthcare | 10.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
76
Dell
DELL
$83.9B
| $299K | 0.03% |
+2,165
| New | +$299K |
|
77
Starbucks
SBUX
$99.2B
| $276K | 0.03% |
3,540
-3,400
| -49% | -$265K |
|
78
Extra Space Storage
EXR
$30.4B
| $272K | 0.03% |
1,750
| – | – |
|
|
79
PNC Financial Services
PNC
$80.7B
| $264K | 0.03% |
1,700
-8,950
| -84% | -$1.39M |
|
80
Beam Therapeutics
BEAM
$1.9B
| $234K | 0.02% |
10,000
| – | – |
|
81
Rivian
RIVN
$17.5B
| $213K | 0.02% |
15,900
| – | – |
|
82
Dow Inc
DOW
$17B
| $212K | 0.02% |
4,000
| – | – |
|
83
MSCI
MSCI
$42.7B
| $202K | 0.02% |
420
| – | – |
|
84
Tyra Biosciences
TYRA
$657M
| $200K | 0.02% |
12,500
-2,500
| -17% | -$40K |
|
85
Tango Therapeutics
TNGX
$745M
| $163K | 0.02% |
19,000
-5,000
| -21% | -$42.9K |
|
86
PMV Pharmaceuticals
PMVP
$82.1M
| $113K | 0.01% |
70,000
-10,000
| -13% | -$16.2K |
|
87
Veralto
VLTO
$26.1B
| – | – |
-2,582
| Closed | -$229K |
|
88
Fiserv
FI
$74.3B
| – | – |
-3,548
| Closed | -$567K |
|
|
89
Diageo
DEO
$61.1B
| – | – |
-10,040
| Closed | -$1.49M |
|
90
Cigna
CI
$80.2B
| – | – |
-881
| Closed | -$320K |
|
91
Citigroup
C
$175B
| – | – |
-3,175
| Closed | -$201K |
|
|
BCYC
92
Bicycle Therapeutics
BCYC
$492M
| – | – |
-9,000
| Closed | -$224K |
|
93
Geron
GERN
$893M
| – | – |
-50,000
| Closed | -$165K |
|